技术平台

New Drug R & D Technology Platform

  • 　　PBMC humanized tumor model 2.0 optimized for low GVHD (Graft vs. Host Disease) and high reconstitution rates.
  • 　　Selective reconstruction technology platform for immune populations (His-T, His-NK, HIS-M).
  • 　　Humanized orthotopic tumor model platform designed to recapitulate the tumor immune microenvironment of the patient.
  • 　　IO (Immuno-Oncology) therapy-resistant tumor model.